Employee stock options are subject to different tax treatments based on their classification. The two main types are Incentive Stock Options (ISOs) and Non-Qualified Stock Options (NSOs). Each type triggers different tax events and has distinct implications.
1. No Ordinary Income on Exercise (Potential Alternative Minimum Tax Impact):
• No regular income tax occurs upon exercise of an ISO; however, the bargain element—the difference between the fair market value at exercise and the exercise (or option) price—may be included for alternative minimum tax (AMT) purposes.
• If the employee meets holding period requirements—holding the stock at least one year after exercise and two years after grant—the eventual gain on sale is treated as long-term capital gain.
• A disqualifying disposition (selling prior to meeting these requirements) results in taxation of the bargain element as ordinary income, with any additional gain potentially taxed as a capital gain.
2. Holding Period Requirements:
• Maintaining proper holding periods is key to achieving favorable long-term capital gain treatment, instead of the ordinary income treatment that applies to a disqualifying disposition.
1. Ordinary Income at Exercise:
• Upon exercise, the bargain element (fair market value at exercise minus the exercise price) is included in the employee’s ordinary income.
• This amount is reported on the employee’s Form W-2, and the employer is entitled to a corresponding deduction.
2. Subsequent Sale of Shares:
• Any subsequent appreciation or depreciation from the time of exercise to the time of sale is treated as a capital gain or loss, depending on the holding period post-exercise.
• The holding period for NSOs begins at the time of exercise. Longer holding periods can result in long-term capital gain treatment on any post-exercise gain.
Tax Timing:
• ISOs do not trigger immediate ordinary income upon exercise (except potential AMT issues), but NSOs do trigger ordinary income at the point of exercise.
Bargain Element:
• The bargain element is the pivotal figure—the difference between the fair market value of the stock at exercise and the option price.
• For ISOs, proper holding periods can defer the ordinary income characterization, while for NSOs, the bargain element is immediately taxable as ordinary income.
Plan Requirements & Disqualifying Dispositions:
• Specific plan document provisions and disqualifying dispositions (failure to meet holding periods) impact whether a portion of the income is treated as ordinary income (in the case of a disqualifying disposition for ISOs) or solely as capital gain.
For ISOs, exercising generally doesn’t trigger immediate income tax, but the bargain element may affect AMT, and a sale must comply with holding period rules to benefit from long-term capital gain treatment. For NSOs, the bargain element is taxed as ordinary income at exercise, with subsequent sales yielding capital gains or losses based on the holding period post-exercise.
This structured approach helps illustrate both the timing and nature of the taxable events associated with employee stock options, drawing on statutory provisions and IRS regulations.
Copyright © 2025 Annette Di Bello, CPA, CFP®, Professional Corporation - All Rights Reserved. Disclaimer: All information herein at Annette Di Bello, CPA, CFP®, Professional Corporation is for informational purposes only. This information does not constitute a solicitation or offer to sell securities or investment advisory services. Annette Di Bello, CPA, CFP®, Professional Corporation is a Registered Investment Advisor transacting business in California and other states in which we qualify for exemptions. Nothing contained herein Annette Di Bello, CPA, CFP®, Professional Corporation website constitutes investment, financial, legal, tax or other advice, nor is to be relied on in making an investment or other decision. Annette Di Bello, CPA, CFP®, Professional Corporation specific advice is prepared only within our contract agreements on a client-by-client basis. Past performance may not be representative of future results.
Offices:
9870 Research Dr, Irvine, CA 92618
355 S Grand Ave, Suite 2450, Los Angeles, CA 90071
2173 Salk Ave, Suite 250, Carlsbad, CA 92008